An Observational, Retrospective, UK & Ireland Audit of Patient Adherence to Rebif® Injections Using the RebiSmart™ Injection Device

Clinical trial NCT01601080 · COMPLETED

Trial details

NCT number: NCT01601080
Sponsor: Merck KGaA, Darmstadt, Germany
Status: COMPLETED
Study type: OBSERVATIONAL

Relapsing Multiple Sclerosis

Start date: 2012-04-01
Primary completion: 2012-10-01
Enrollment: 230

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.